Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Skin and Connective Tissue Diseases; Stomatognathic Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.708 | 0.520 | 14 | 35401887 | 3 prime UTR variant | C/T | snv | 0.45 |
|
Digestive System Diseases; Infections | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.732 | 0.440 | 14 | 35405593 | upstream gene variant | G/A | snv | 0.26 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.732 | 0.440 | 14 | 35405593 | upstream gene variant | G/A | snv | 0.26 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.732 | 0.440 | 14 | 35405593 | upstream gene variant | G/A | snv | 0.26 |
|
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 |